(Q34791108)

4 August 2017

1 reference

title

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses (English)

1 reference

4 August 2017

Cassian Yee

1

1 reference

4 August 2017

Philip Greenberg

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

4 August 2017

Nature Reviews Cancer

1 reference

4 August 2017

2

1 reference

4 August 2017

409-419

1 reference

4 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc820

4 August 2017

0 references

cites work

T cell defined tumor antigens

1 reference

Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience

21 January 2018

1 reference

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

21 January 2018

1 reference

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

21 January 2018

1 reference

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

Direct transfection and activation of human cutaneous dendritic cells

21 January 2018

1 reference

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

21 January 2018

1 reference

Prospects for adoptive T cell therapy

21 January 2018

1 reference

Clinical trial designs for the early clinical development of therapeutic cancer vaccines

21 January 2018

1 reference

CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer

21 January 2018

1 reference

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

21 January 2018

1 reference

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

21 January 2018

1 reference

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

21 January 2018

1 reference

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

21 January 2018

1 reference

In situ detection of virus- and tumor-specific T-cell immunity

21 January 2018

1 reference

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

21 January 2018

1 reference

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

21 January 2018

1 reference

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

21 January 2018

1 reference

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

21 January 2018

1 reference

Flow cytometric measurement of intracellular cytokines.

21 January 2018

1 reference

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

21 January 2018

1 reference

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

21 January 2018

1 reference

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

21 January 2018

1 reference

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens

21 January 2018

1 reference

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model.

21 January 2018

1 reference

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

21 January 2018

1 reference

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells

21 January 2018

1 reference

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review

21 January 2018

1 reference

Colonic carcinoma.A quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis

21 January 2018

1 reference

The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer

21 January 2018

1 reference

Activation of cytotoxic T cells by solid tumours?

21 January 2018

1 reference

Bioluminescence imaging of lymphocyte trafficking in vivo.

21 January 2018

1 reference

CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.

21 January 2018

1 reference

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

21 January 2018

1 reference

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

21 January 2018

1 reference

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

21 January 2018

1 reference

Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

21 January 2018

1 reference

A kinetic basis for T cell receptor repertoire selection during an immune response

21 January 2018

1 reference

Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation

21 January 2018

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

21 January 2018

1 reference

Role of TGF-beta in immune-evasion of cancer

21 January 2018

1 reference

The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival

21 January 2018

1 reference

Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

21 January 2018

1 reference

Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein

21 January 2018

1 reference

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1

21 January 2018

1 reference

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

T cell antigen receptor vaccines for active therapy of T cell malignancies.

21 January 2018

1 reference

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

31 March 2020

1 reference

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

31 March 2020

1 reference

Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington

31 March 2020

1 reference

Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine

31 March 2020

1 reference

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

31 March 2020

1 reference

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

31 March 2020

1 reference

Monitoring antigen-specific T cells using MHC-Ig dimers

31 March 2020

1 reference

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

31 March 2020

1 reference

Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness

31 March 2020

1 reference

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

31 March 2020

1 reference

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

31 March 2020

1 reference

Expression of a tolerizing tumor antigen in peripheral tissue does not preclude recovery of high-affinity CD8+ T cells or CTL immunotherapy of tumors expressing the antigen

31 March 2020

1 reference

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

31 March 2020

1 reference

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

31 March 2020

1 reference

MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen

31 March 2020

1 reference

Isolation of multiple mRNAs from a few eukaryotic cells: a fast method to obtain templates for RT-PCR

31 March 2020

1 reference

Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR

31 March 2020

1 reference

Immunotherapy through TCR gene transfer

31 March 2020

1 reference

Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A/MART-1

31 March 2020

1 reference

Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases

31 March 2020

1 reference

Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing

31 March 2020

1 reference

Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression

31 March 2020

1 reference

A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death

31 March 2020

1 reference

Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC820

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference